Corporate Social Responsibility | Business Wire | PR NewsWire | Marketwire | Realwire | ACN/JCN newswire | 247pressrelease | PRWeb

OssulinTM, a Novel Oral Insulin Product, Shows Promising Bioavailability for Advancing Diabetes Therapy

Posted : Mon, 09 Nov 2009 10:00:37 GMT
Author : CM&D Pharma Limited
Category : Press Release
News Alerts by Email ( click here )
News | Home
LONDON - (Business Wire) New data from Puredel Limited, presented at the 9th Annual Diabetes Technology Meeting in San Francisco, CA, suggests that higher blood levels of insulin were achieved by Ossulin™ than had been previously demonstrated by other oral products. In a series of experiments covering a range of doses and models, Ossulin™ consistently delivered around 20% of the insulin dose into the bloodstream.

The authors concluded that:

"Ossulin provides an efficient way to deliver insulin to the body via oral administration, resulting in blood levels higher than those previously observed with other oral insulin products."

Lead author and Chief Scientific Officer for Puredel, Dr. Marco Prosdocimi added:

"Oral insulin could represent a major advance in diabetes therapy through its simplicity of use, and because it mimics the natural physiological route of the hormone. The incorporation of insulin into the proprietary delivery agent NatsomTM gives rise to a product which is not destroyed by the gastric environment."

About Puredel Limited

Puredel is focusing its research on the development of Ossulin™, which has shown promising results in preliminary studies. Puredel will also explore other target molecules which are currently injected, and whose oral administration would greatly improve patient convenience and compliance. Natreon’s R&D staff and facilities in the United States and India are working closely with Puredel to help facilitate the next stage of scientific validation prior to commercial development.

Puredel will coordinate the product development of Ossulin™ up to proof of clinical efficacy, drawing on its extensive network of scientific experts in Europe and North America.

For further information and a copy of the abstract, please contact:
Stephen Appelbee, CEO, CM&D Pharma Limited
+44 20 7259 8488

appelbee@cmdpharmaltd.com

www.cmdpharmaltd.com

CM&D Pharma Limited
Stephen Appelbee, CEO, +44 20 7259 8488
appelbee@cmdpharmaltd.com
www.cmdpharmaltd.com


Copyright © 2008 Business Wire. All rights reserved.
Share/Save/Bookmark

Article : OssulinTM, a Novel Oral Insulin Product, Shows Promising Bioavailability for Advancing Diabetes Therapy
Print this article
Share this article

Stay Updated

News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Related News

TechNet Applauds Administration's New Program to Encourage U.S. Students to Pursue Studies in Science, Technology, Engineering and Math
WASHINGTON, Nov. 23 /PRNewswire-USNewswire/ -- TechNet, the bipartisan political network of CEOs that promotes the growth of the innovation economy, today applauded the Obama Administration for its announcement of a new initiative to fortify the nation's economic future by encouragi...

Governor General Meets with the Grand Temoin de la Francophonie for the 2010 Winter Games in Vancouver
OTTAWA, ONTARIO -- 11/23/09 -- Her Excellency the Right Honourable Michaelle Jean, Governor of Canada, met with Mr. Pascal Couchepin, Grand Temoin de la Francophonie for the Vancouver 2010 Olympic and Paralympic Winter Games. During their..

Adesta and Future Fibre Technologies Selected to Provide Security Systems for Washington Dulles International Airport
A forward thinking strategy that will ensure cost-effective upgrades and energy efficiencies is the obvious choice for the Airport Authority. /I/P POmaha, NE (Vocus) November 23, 2009 -- Adesta, a systems integrator and project management company for communication networks and electron...

Fitch Rates Richmond, Virginia's $113MM GOs 'AA'; Outlook Stable
NEW YORK - Fitch Ratings assigns an 'AA' rating to the City of Richmond, Virginia's $112.82 million general obligation (GO) bonds, consisting of: --$79.01 million GO public improvement bonds, series 2009A; --$33.81 million GO public improvement refunding bonds

Johnson Service Group Acquires TechSource
ATLANTA, GA -- 11/23/09 -- Johnson Service Group, Inc. ("JSG"), a leading nationwide provider of contract engineering, technical and professional personnel, today announced the acquisition of the business and operations of TechSource, Inc. based in..

Sendmail and Axway Announce Out-of-Court Settlement of Patent Infringement Disputes
Sendmail, Inc. and Axway have agreed to an out-of-court settlement of their disputes relating to U.S. patents/I/P PEmeryville, Calif. and Scottsdale, Ariz. (PRWEB) November 23, 2009 -- Sendmail, Inc. and Axway announced today that they have agreed to an out-of-court settlement of their ...

Cogent Communications CEO to Present at J.P. Morgan's SMid Cap Conference
WASHINGTON, Nov. 23 -- Cogent Communications Group, Inc. (Nasdaq: CCOI), one of the largest Internet service providers in the world, today announced that Dave Schaeffer, Cogent's chief executive officer, will present at J.P. Morgan's SMid Cap Conference at 3:45 p....

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark
 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.